drugset / Trial / NCT01170884

Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®

NCT01170884

Phase 4 Completed 121 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

Comparing Safety and Efficacy of Combigan® and Lumigan® with Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated with Xalatan®.

Timeline

Start
2009-12
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule 0.2 % Other
Comparator Timolol Other / unclassified 0.5 % Other
Comparator Bimatoprost Other / unclassified 0.03 % Other
Comparator Hypromellose Unknown 0.2 % Other